| ²é¿´: 1101 | »Ø¸´: 9 | |||
| ¡¾½±Àø¡¿ ±¾Ìû±»ÆÀ¼Û8´Î£¬×÷Õßrz9348Ôö¼Ó½ð±Ò 5.6 ¸ö | |||
[×ÊÔ´]
Èιú±öÀÏʦ¿ÎÉÏ˵µÄ¹¤Òµ½á¾§Ö¸µ¼ÔÔò
|
|||
| Èιú±öÀÏʦ¿ÎÉÏ˵µÄ¹¤Òµ½á¾§Ö¸µ¼ÔÔò |
» ±¾Ìû¸½¼þ×ÊÔ´Áбí
-
»¶Ó¼à¶½ºÍ·´À¡£ºÐ¡Ä¾³æ½öÌṩ½»Á÷ƽ̨£¬²»¶Ô¸ÃÄÚÈݸºÔð¡£
±¾ÄÚÈÝÓÉÓû§×ÔÖ÷·¢²¼£¬Èç¹ûÆäÄÚÈÝÉæ¼°µ½ÖªÊ¶²úȨÎÊÌ⣬ÆäÔðÈÎÔÚÓÚÓû§±¾ÈË£¬Èç¶Ô°æÈ¨ÓÐÒìÒ飬ÇëÁªÏµÓÊÏ䣺xiaomuchong@tal.com - ¸½¼þ 1 : Guidance_for_Industry£»ANDAs_Pharmaceutical_Solid_Polymorphism£¨draft£¬2004°æ£©.pdf
- ¸½¼þ 2 : Guidance_for_Industry£»ANDAs_Pharmaceutical_Solid_Polymorphism£¨¶¨¸å£¬2007°æ£©.pdf
2017-08-26 07:48:26, 192 K
2017-08-26 07:48:27, 124.81 K
» ÊÕ¼±¾ÌûµÄÌÔÌûר¼ÍƼö
ÖØ½á¾§ ¹¤Òµ½á¾§ |
» ²ÂÄãϲ»¶
¡¾¸ßУÁªºÏ¾Ù°ì¡¿2026ÄêµÚÎå½ì·þÎñ»úÆ÷È˹ú¼Ê»áÒ飨ICoSR 2026£©
ÒѾÓÐ0È˻ظ´
ÉîÛÚ´óѧ»¯Ñ§Óë»·¾³¹¤³ÌѧԺ³¬·Ö×ÓÍŶÓÕÐÊÕ2026¼¶ÉêÇë-¿¼ºËÖÆ²©Ê¿Éú
ÒѾÓÐ8È˻ظ´
ÎÞ»ú»¯Ñ§ÂÛÎÄÈóÉ«/·ÒëÔõôÊÕ·Ñ?
ÒѾÓÐ221È˻ظ´
ÖÐÄÏ´óѧ»¯Ñ§»¯¹¤Ñ§ÔºÒ×СÒÕ½ÌÊÚ¿ÎÌâ×éÕÐÊÕ2026¼¶²©Ê¿Ñо¿Éú£¨µÚ¶þÂÖ£©
ÒѾÓÐ0È˻ظ´
ÇóÖú
ÒѾÓÐ0È˻ظ´
0703»¯Ñ§26¿¼Ñе÷¼Á£¬Ò»Ö¾Ô¸Äϲý´óѧ
ÒѾÓÐ2È˻ظ´
ÓÐûÓл¯Ñ§¡¢²ÄÁÏרҵµÄͬѧÐèÒªµ÷¼Á ¿¼ÂÇÌì½ò¸ßЧµÄ¿ÉÒÔÓʼþ»òÕß˽ÐÅ
ÒѾÓÐ1È˻ظ´
26Ä격ʿÕÐÉú
ÒѾÓÐ15È˻ظ´
½Î÷Àí¹¤´óѧ¹¦Äܾ§Ì¬²ÄÁÏ·½ÏòÁõËì¾ü¿ÎÌâ×éÕÐÊÕ2026ÄêÇï¼¾Èëѧ²©Ê¿Ñо¿Éú
ÒѾÓÐ10È˻ظ´
ÄþÏÄ´óѧÍÅ´ØÐ²ÄÁÏÍŶÓÕÐÊÕ²ÄÁÏ/»¯Ñ§/»¯¹¤×¨Òµ²©Ê¿Éú
ÒѾÓÐ0È˻ظ´
9Â¥2024-04-04 15:41:38
¼òµ¥»Ø¸´
tayu2Â¥
2017-09-06 14:06
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
leifeng3Â¥
2017-09-10 21:44
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
hzqlj4Â¥
2018-07-31 09:06
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
YTB543215Â¥
2019-05-11 16:16
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
xmc1411186Â¥
2019-05-12 05:43
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
superwang7Â¥
2019-05-16 18:32
»Ø¸´
ÎåÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
rz93488Â¥
2023-06-30 14:12
»Ø¸´
¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡
shill200310Â¥
2024-05-31 10:29
»Ø¸´
ÈýÐÇºÃÆÀ ¶¥Ò»Ï£¬¸Ðл·ÖÏí£¡













»Ø¸´´ËÂ¥
20